StockData
OPKO Health, Inc. logo

OPKO Health, Inc. (OPK) stock

OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.62+0.00 (0.00%)

Close on Nov 17, 2026Market cap $1.21BP/E –Yield –

OPKO Health r&d expenses

Research and development expenses are spending on new products and technology.

OPKO Health's R&D Expenses for the twelve months ending Jun 30, 2026 was $125.22M, up 4.0% year over year. For fiscal 2025 it was $124.03M, up 17.9% from the year before. Over ten years it grew 2.2% a year on average. The highest annual figure on record is $126.44M in fiscal 2017.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$124.03M+17.9%
FY2024Dec 31, 2024$105.21M+17.4%
FY2023Dec 31, 2023$89.59M+21.3%
FY2022Dec 31, 2022$73.89M-3.9%
FY2021Dec 31, 2021$76.85M+2.0%
FY2020Dec 31, 2020$75.32M-36.1%
FY2019Dec 31, 2019$117.87M-6.1%
FY2018Dec 31, 2018$125.59M-0.7%
FY2017Dec 31, 2017$126.44M+11.0%
FY2016Dec 31, 2016$113.87M+14.5%
FY2015Dec 31, 2015$99.49M+19.0%
FY2014Dec 31, 2014$83.57M+55.0%
FY2013Dec 31, 2013$53.90M+176.1%
FY2012Dec 31, 2012$19.52M+72.0%
FY2011Dec 31, 2011$11.35M+90.8%
FY2010Dec 31, 2010$5.95M-45.1%
FY2009Dec 31, 2009$10.84M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$33.17M+9.3%
Q1 FY2026Mar 31, 2026$29.20M-5.3%
Q4 FY2025Dec 31, 2025$32.77M+7.7%
Q3 FY2025Sep 30, 2025$30.08M+4.5%
Q2 FY2025Jun 30, 2025$30.34M+26.0%
Q1 FY2025Mar 31, 2025$30.84M+40.6%
Q4 FY2024Dec 31, 2024$30.43M+56.9%
Q3 FY2024Sep 30, 2024$28.77M+48.0%
Q2 FY2024Jun 30, 2024$24.08M+32.6%
Q1 FY2024Mar 31, 2024$21.94M-32.7%
Q4 FY2023Dec 31, 2023$19.39M-0.7%
Q3 FY2023Sep 30, 2023$19.44M+3.4%
Q2 FY2023Jun 30, 2023$18.16M+5.2%
Q1 FY2023Mar 31, 2023$32.61M+78.1%
Q4 FY2022Dec 31, 2022$19.53M-7.0%
Q3 FY2022Sep 30, 2022$18.79M+2.7%
Q2 FY2022Jun 30, 2022$17.25M-5.3%
Q1 FY2022Mar 31, 2022$18.31M-5.2%
Q4 FY2021Dec 31, 2021$21.01M+20.4%
Q3 FY2021Sep 30, 2021$18.31M-1.0%
Q2 FY2021Jun 30, 2021$18.22M+3.5%
Q1 FY2021Mar 31, 2021$19.32M-11.2%
Q4 FY2020Dec 31, 2020$17.45M-24.2%
Q3 FY2020Sep 30, 2020$18.49M-38.4%
Q2 FY2020Jun 30, 2020$17.61M-37.8%
Q1 FY2020Mar 31, 2020$21.76M-40.4%
Q4 FY2019Dec 31, 2019$23.04M-30.9%
Q3 FY2019Sep 30, 2019$30.02M-0.5%
Q2 FY2019Jun 30, 2019$28.29M-3.2%
Q1 FY2019Mar 31, 2019$36.53M+11.1%
Q4 FY2018Dec 31, 2018$33.33M-2.7%
Q3 FY2018Sep 30, 2018$30.16M-7.2%
Q2 FY2018Jun 30, 2018$29.21M-11.8%
Q1 FY2018Mar 31, 2018$32.89M+23.8%
Q4 FY2017Dec 31, 2017$34.24M+13.1%
Q3 FY2017Sep 30, 2017$32.51M+33.1%
Q2 FY2017Jun 30, 2017$33.13M–
Q1 FY2017Mar 31, 2017$26.56M–
Q4 FY2016Dec 31, 2016$30.28M–
Q3 FY2016Sep 30, 2016$24.42M–

More OPKO Health figures

See a number that looks wrong?